Survival study of hospitalised patients with concurrent COVID‐19 and haematological malignancies
Open Access
- 27 May 2020
- journal article
- letter
- Published by Wiley in British Journal of Haematology
- Vol. 190 (1) , E16-E20
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortalityInternational Journal of Antimicrobial Agents, 2020
- COVID-19 in persons with haematological cancersLeukemia, 2020
- COVID-19 and Cancer: Lessons From a Pooled Meta-AnalysisJCO Global Oncology, 2020
- Care of haematology patients in a COVID‐19 epidemicBritish Journal of Haematology, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet Oncology, 2020